Physician profile
Frank C Young
NPI 1376547075
$1,761.05
in general payments reported to CMS, 2019-2025
16 companies · $56.11 in 2025
The $56.11 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $350 · 2021: $238 · 2022: $229 · 2023: $183 · 2024: $338 · 2025: $56.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Entertainment: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.96 |
| Entertainment | $117.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $314.90 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Allergan, INC. | $293.79 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $259.80 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $181.57 | 2019-2021 | |
| Ocular Therapeutix, INC. | $145.71 | 2019-2023 | Dextenza |
| Abbvie INC. | $131.53 | 2022-2023 | Lumigan |
| Johnson & Johnson Surgical Vision, INC. | $123.48 | 2019-2024 | Amo Phaco Needle |
| Optos, INC. | $117.86 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $43.32 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $41.54 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.91 | 2019 | |
| Astellas Pharma US INC | $20.12 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $19.86 | 2021 | |
| Omeros Corporation | $15.70 | 2021 | |
| Horizon Therapeutics Plc | $14.06 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beaver-Visitec International, INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.